an immune profile score based on the t-cell count , b-cell count , lymphocyte response to mitogens , and serum iga level was useful in predicting the subsequent development of malignant trophoblastic disease in patients with hydatidiform mole but was not helpful in predicting resistance to chemotherapy in malignant trophoblastic disease .
C0020217
hydatidiform mole
C2931618
trophoblastic disease